Rheumatology
| Rheumatoid Arthritis
Rheumatology
Rheumatoid Arthritis

Major adverse cardiovascular events and mortality with opioids versus NSAIDs initiation in patients with rheumatoid arthritis

book_2 Source: Ann Rheum Dis.2023;82(11):1487-1494.
calendar_today Published on Medfyle: November 2023
import_contacts 7 min
headphones 7 min

In this medfyle

Pain is a common problem in RA, and opioids are commonly used. But in addition to their known addiction and overdose risks, opioids can increase proinflammatory cytokines, and may represent a CVD risk. This study set out to compare MACE and death with opioids versus NSAID.

This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.

Expert commentary

David S. Pisetsky, MD, PhD

Professor of Medicine and Immunology
Duke University Medical Center
Durham, NC USA

About this Medfyle
Read more arrow_downward Hide arrow_upward

©2023 Medfyle. All rights reserved.

Original article:

Ozen G, Pedro S, Michaud K. Major adverse cardiovascular events and mortality with opioids versus NSAIDs initiation in patients with rheumatoid arthritis. Ann Rheum Dis. 2023 Nov;82(11):1487-1494. doi: 10.1136/ard-2023-224339. Epub 2023 Jul 17. PMID: 37460169.

The authors of the original article and the publisher were not involved in the creation of the summary.


Feedback